• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4598975)   Today's Articles (4660)   Subscriber (49356)
For: Cosson E, Nguyen M, Balta C, Pariès J, Valensi P. O54 Intérêt des recommandations Alfediam-SFC (RECO) sélectionnant les diabétiques à risque d’ischémie myocardique silencieuse (IMS). Une étude de suivi avec analyse des changements de pratique depuis 1992. Diabetes & Metabolism 2008. [DOI: 10.1016/s1262-3636(08)72864-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Number Cited by Other Article(s)
1
Valensi P, Cosson E. It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia. DIABETES & METABOLISM 2010;36:91-6. [DOI: 10.1016/j.diabet.2010.01.001] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/13/2009] [Revised: 01/14/2010] [Accepted: 01/18/2010] [Indexed: 10/19/2022]
2
Valensi P. Silent myocardial ischaemia. To screen or not to screen? That is... Arch Cardiovasc Dis 2008;101:509-11. [PMID: 19041833 DOI: 10.1016/j.acvd.2008.10.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA